Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Lucid Group | LCID | 15. nov 2024 | 2.01 | -3.37 |
Lufax ADR | LU | 15. nov 2024 | 2.31 | -0.86 |
Lululemon Athletica | LULU | 15. nov 2024 | 320.01 | -3.10 |
Lulus Fashion Lounge | LVLU | 15. nov 2024 | 1.43 | +1.06 |
Lumen Technologies | LUMN | 15. nov 2024 | 8.54 | -1.04 |
Lument Finance Trust | LFT | 15. nov 2024 | 2.52 | +2.44 |
Lument Finance Trust A Pref | LFT-A | 15. nov 2024 | 22.74 | -1.77 |
Lumentum | LITE | 15. nov 2024 | 81.45 | -4.32 |
Luminar Technologies A | LAZR | 15. nov 2024 | 0.98 | -4.85 |
Lumos Pharma | LUMO | 15. nov 2024 | 4.33 | 0.00 |
Luna Innovations | LUNA | 15. nov 2024 | 1.63 | +3.82 |
Luokung Technology | LKCO | 15. nov 2024 | 1.68 | +1.02 |
Luxfer | LXFR | 15. nov 2024 | 14.34 | -2.12 |
LuxUrban Hotels | LUXH | 15. nov 2024 | 0.04 | -6.59 |
Luxurban Hotels Pref | LUXHP | 15. nov 2024 | 15.60 | -2.50 |
Lxp Industrial Trust | LXP | 15. nov 2024 | 9.18 | -0.86 |
LXP Industrial Trust C Pref | LXP-C | 15. nov 2024 | 50.56 | +0.70 |
Lyell Immunopharma | LYEL | 15. nov 2024 | 1.10 | 0.00 |
Lyft A | LYFT | 15. nov 2024 | 18.12 | +1.12 |
LyondellBasell Industries Nv A | LYB | 15. nov 2024 | 82.65 | +0.11 |
Lyra Therapeutics | LYRA | 15. nov 2024 | 0.17 | -5.56 |
Lytus Technologies | LYT | 15. nov 2024 | 1.69 | -5.06 |
M&T Bank | MTB | 15. nov 2024 | 214.74 | +0.69 |
M&T Bank ADR Prej J | MTB-J | 15. nov 2024 | 27.39 | -0.33 |
M&T Bank H Pref | MTB-H | 15. nov 2024 | 25.25 | -0.59 |
M-tron Industries | MPTI | 15. nov 2024 | 56.40 | -5.72 |
M/I Homes | MHO | 15. nov 2024 | 155.47 | +0.39 |
M3-Brigade Acquisition V | MBAVU | 15. nov 2024 | 10.60 | +3.75 |
M3-Brigade Acquisition V | MBAV | 15. nov 2024 | 10.03 | 0.00 |
Macerich | MAC | 15. nov 2024 | 19.27 | +0.21 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.